世界の心血管ペーシングおよび植え込み型除細動器(ICD)リード市場:医療機器パイプライン分析2016

◆英語タイトル:Cardiovascular Pacing and Implantable Cardioverter-Defibrillator (ICD) Leads - Medical Devices Pipeline Assessment, 2016
◆商品コード:GDME0203EPD
◆発行会社(調査会社):GlobalData
◆発行日:2016年6月6日
◆ページ数:87
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆調査対象地域:グローバル
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single UserUSD2,500 ⇒換算¥277,500見積依頼/購入/質問フォーム
Site License(同一国内共有可)USD5,000 ⇒換算¥555,000見積依頼/購入/質問フォーム
Enterprisewide License(複数国内共有可)USD7,500 ⇒換算¥832,500見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご確認ください。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。(支払期限と方法は調整可能、振込先:三菱東京UFJ銀行/京橋支店/H&Iグローバルリサーチ株式会社)
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。GlobalData社の概要及び新刊レポートはこちらでご確認いただけます。
当調査レポートでは、心血管ペーシングおよび植え込み型除細動器(ICD)リードのグローバル製品パイプライン動向について調査・分析し、以下の構成でお届けいたします。
・心血管ペーシングおよび植え込み型除細動器(ICD)リードの概要
・心血管ペーシングおよび植え込み型除細動器(ICD)リードの開発動向:開発段階別分析
・心血管ペーシングおよび植え込み型除細動器(ICD)リードの開発動向:セグメント別分析
・心血管ペーシングおよび植え込み型除細動器(ICD)リードの開発動向:領域別分析
・心血管ペーシングおよび植え込み型除細動器(ICD)リードの開発動向:規制Path別分析
・心血管ペーシングおよび植え込み型除細動器(ICD)リードの開発動向:承認日(推定)別分析
・企業別心血管ペーシングおよび植え込み型除細動器(ICD)リードの開発動向(パイプライン製品、進行中の治験)
・心血管ペーシングおよび植え込み型除細動器(ICD)リードの最近動向
【レポートの概要】

Cardiovascular Pacing and Implantable Cardioverter-Defibrillator (ICD) Leads – Medical Devices Pipeline Assessment, 2016

Summary

GlobalData’s Medical Devices sector report, “Cardiovascular Pacing and Implantable Cardioverter-Defibrillator (ICD) Leads – Medical Devices Pipeline Assessment, 2016″ provides an overview of Cardiovascular Pacing and Implantable Cardioverter-Defibrillator (ICD) Leads currently in pipeline stage.

The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Cardiovascular Pacing and Implantable Cardioverter-Defibrillator (ICD) Leads pipeline products.

This report is prepared using data sourced from in-house databases, secondary and primary research by GlobalData’s team of industry experts.

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope

- Extensive coverage of the Cardiovascular Pacing and Implantable Cardioverter-Defibrillator (ICD) Leads under development
- The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
- The report reviews the major players involved in the development of Cardiovascular Pacing and Implantable Cardioverter-Defibrillator (ICD) Leads and list all their pipeline projects
- The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
- The report provides key clinical trial data of ongoing trials specific to pipeline products
- Recent developments in the segment / industry

Reasons to buy

The report enables you to –
- Formulate significant competitor information, analysis, and insights to improve R&D strategies
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Identify and understand important and diverse types of Cardiovascular Pacing and Implantable Cardioverter-Defibrillator (ICD) Leads under development
- Develop market-entry and market expansion strategies
- Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
- In-depth analysis of the product’s current stage of development, territory and estimated launch date

【レポートの目次】

1 Table of Contents
1 Table of Contents 2
1.1 List of Tables 4
1.2 List of Figures 6
2 Introduction 7
2.1 Cardiovascular Pacing and Implantable Cardioverter-Defibrillator (ICD) Leads Overview 7
3 Products under Development 8
3.1 Cardiovascular Pacing and Implantable Cardioverter-Defibrillator (ICD) Leads – Pipeline Products by Stage of Development 8
3.2 Cardiovascular Pacing and Implantable Cardioverter-Defibrillator (ICD) Leads – Pipeline Products by Territory 9
3.3 Cardiovascular Pacing and Implantable Cardioverter-Defibrillator (ICD) Leads – Pipeline Products by Regulatory Path 10
3.4 Cardiovascular Pacing and Implantable Cardioverter-Defibrillator (ICD) Leads – Pipeline Products by Estimated Approval Date 11
3.5 Cardiovascular Pacing and Implantable Cardioverter-Defibrillator (ICD) Leads – Ongoing Clinical Trials 12
4 Cardiovascular Pacing and Implantable Cardioverter-Defibrillator (ICD) Leads – Pipeline Products under Development by Companies 13
4.1 Cardiovascular Pacing and Implantable Cardioverter-Defibrillator (ICD) Leads Companies – Pipeline Products by Stage of Development 13
4.2 Cardiovascular Pacing and Implantable Cardioverter-Defibrillator (ICD) Leads – Pipeline Products by Stage of Development 14
5 Cardiovascular Pacing and Implantable Cardioverter-Defibrillator (ICD) Leads Companies and Product Overview 15
5.1 Boston Scientific Corporation Company Overview 15
5.1.1 Boston Scientific Corporation Pipeline Products & Ongoing Clinical Trials Overview 15
5.2 Imricor Medical Systems, Inc. Company Overview 25
5.2.1 Imricor Medical Systems, Inc. Pipeline Products & Ongoing Clinical Trials Overview 25
5.3 LivaNova PLC Company Overview 26
5.3.1 LivaNova PLC Pipeline Products & Ongoing Clinical Trials Overview 26
5.4 Mayo Clinic US Company Overview 33
5.4.1 Mayo Clinic US Pipeline Products & Ongoing Clinical Trials Overview 33
5.5 Medtronic plc Company Overview 35
5.5.1 Medtronic plc Pipeline Products & Ongoing Clinical Trials Overview 35
5.6 MicroPort Scientific Corporation Company Overview 38
5.6.1 MicroPort Scientific Corporation Pipeline Products & Ongoing Clinical Trials Overview 38
5.7 MRI Interventions, Inc Company Overview 40
5.7.1 MRI Interventions, Inc Pipeline Products & Ongoing Clinical Trials Overview 40
5.8 St. Jude Medical, Inc. Company Overview 42
5.8.1 St. Jude Medical, Inc. Pipeline Products & Ongoing Clinical Trials Overview 42
5.9 Teleflex Incorporated Company Overview 49
5.9.1 Teleflex Incorporated Pipeline Products & Ongoing Clinical Trials Overview 49
6 Cardiovascular Pacing and Implantable Cardioverter-Defibrillator (ICD) Leads- Recent Developments 50
6.1 May 31, 2016: Medtronic Reports Fourth Quarter and Fiscal Year 2016 Financial Results 50
6.2 May 04, 2016: Medtronic Welcomes Karen L. Parkhill as Its New Chief Financial Officer 52
6.3 Apr 28, 2016: Boston Scientific Announces Scheduled Presentation on Acuity X4 Quad LV Lead At Heart Rhythm Society 2016 53
6.4 Apr 27, 2016: Abbott Labs to Acquire St. Jude Medical for up to USD25 Billion 54
6.5 Apr 25, 2016: Boston Scientific Receives U.S. FDA Approval For ImageReady MR-Conditional Pacing System 54
6.6 Apr 20, 2016: BIOTRONIK ICD Lead Data from Long-Term Registries Published by Journal of Cardiovascular Electrophysiology 55
6.7 Apr 20, 2016: St. Jude Medical Reports First Quarter 2016 Results 56
6.8 Apr 06, 2016: Medtronic Statement on U.S. Department of Treasury’s Recent Temporary and Proposed Regulations 57
6.9 Mar 29, 2016: St. Jude Medical Announces CE Mark Approval and Launch of Expanded Selection of Quadripolar Pacing Leads 57
6.10 Mar 17, 2016: Medtronic Proposes Proxy Access 59
6.11 Mar 01, 2016: Medtronic Reports Third Quarter Financial Results 59
6.12 Feb 23, 2016: Boston Scientific Receives U.S. FDA Approval For Quadripolar Leads And Initiates Global Trial To Expand MRI Labeling To The U.S. And Asia 61
6.13 Feb 19, 2016: Medtronic to Announce Financial Results for Its Third Quarter of Fiscal Year 2016 61
6.14 Feb 17, 2016: St. Jude Medical Receives FDA Approval for Industry’s First MultiPoint Pacing Technology 62
6.15 Jan 27, 2016: St. Jude Medical Reports Fourth Quarter and Full-Year 2015 Results 63
6.16 Jan 22, 2016: FDA Classifies St. Jude Medical Field Action for 447 of the Company’s Optisure High Voltage Leads as a Class 1 Advisory in the U.S. 65
6.17 Jan 13, 2016: St. Jude Medical Announces Preliminary Fourth Quarter 2015 Financial Results 66
6.18 Jan 11, 2016: Medtronic Updates Capital Allocation Plans and Fiscal 2016 EPS Guidance 67
6.19 Dec 14, 2015: The Medtronic Bakken Invitation Award Honors 12 Patients from Around the World for Giving Back 68
6.20 Nov 30, 2015: Boston Scientific Retrieves Certain Lots Of 9Fr ACUITY Pro Coronary Sinus Outer Guide Catheters 68
6.21 Nov 20, 2015: Medtronic Statement on U.S. Department of Treasury’s Notice 2015-79 69
6.22 Oct 21, 2015: St. Jude Medical Reports Third Quarter 2015 Results 69
6.23 Sep 28, 2015: Medtronic InFuse Lawsuit May Reach Supreme Court, Parker Waichman LLP Comments 70
6.24 Sep 14, 2015: Incoming St. Jude Medical President and CEO Mike Rousseau Announces Executive Leadership Team 71
6.25 Sep 10, 2015: Sorin and Cyberonics Announce Appointment of LivaNova’s Chief Financial Officer 72
6.26 Sep 09, 2015: St. Jude Medical Announces Leadership Transition Plan 72
6.27 Sep 08, 2015: No Further Legal Action By Italian State’s Attorney To Enjoin The Combination Of Sorin And Cyberonics 73
6.28 Sep 03, 2015: Medtronic Reports First Quarter Financial Results 74
6.29 Aug 05, 2015: St. Jude Medical Appoints David Dvorak to Its Board of Directors 76
6.30 Jul 30, 2015: Sorin Group Announces Results for the Second Quarter of 2015 77
6.31 Jul 27, 2015: Sorin And Cyberonics Announce Intent To Vigorously Contest Claim By Italian State’s Attorney Seeking To Enjoin The Proposed Combination Of The Companies 79
6.32 Jul 22, 2015: St. Jude Medical Reports Second Quarter 2015 Results 80
6.33 Jul 14, 2015: Malaysia, The Hub Of Medical Device Manufacturing In Asean 81
6.34 Jun 25, 2015: Sorin And Cyberonics Unveil Name Of Combined Company: LivaNova 82
7 Appendix 84
7.1 Methodology 84
7.2 About GlobalData 86
7.3 Contact Us 87
7.4 Disclaimer 87

1.1 List of Tables
Table 1: Cardiovascular Pacing and Implantable Cardioverter-Defibrillator (ICD) Leads - Pipeline Products by Stage of Development 8
Table 2: Cardiovascular Pacing and Implantable Cardioverter-Defibrillator (ICD) Leads - Pipeline Products by Territory 9
Table 3: Cardiovascular Pacing and Implantable Cardioverter-Defibrillator (ICD) Leads - Pipeline Products by Regulatory Path 10
Table 4: Cardiovascular Pacing and Implantable Cardioverter-Defibrillator (ICD) Leads - Pipeline Products by Estimated Approval Date 11
Table 5: Cardiovascular Pacing and Implantable Cardioverter-Defibrillator (ICD) Leads - Ongoing Clinical Trials 12
Table 6: Cardiovascular Pacing and Implantable Cardioverter-Defibrillator (ICD) Leads Companies - Pipeline Products by Stage of Development 13
Table 7: Cardiovascular Pacing and Implantable Cardioverter-Defibrillator (ICD) Leads - Pipeline Products by Stage of Development 14
Table 8: Boston Scientific Corporation Pipeline Products & Ongoing Clinical Trials Overview 15
Table 9: ENDOTAK RELIANCE 4-SITE Defibrillation Lead System - Product Status 15
Table 10: ENDOTAK RELIANCE 4-SITE Defibrillation Lead System - Product Description 16
Table 11: INGEVITY Pacing Lead - Product Status 16
Table 12: INGEVITY Pacing Lead - Product Description 16
Table 13: Next Generation ICD Lead - Product Status 17
Table 14: Next Generation ICD Lead - Product Description 17
Table 15: Reliance 4-Front Lead - Product Status 17
Table 16: Reliance 4-Front Lead - Product Description 18
Table 17: X4 SYSTEM + QUAD LEAD - Product Status 18
Table 18: X4 SYSTEM + QUAD LEAD - Product Description 18
Table 19: Boston Scientific Corporation - Ongoing Clinical Trials Overview 19
Table 20: ENDOTAK RELIANCE 4-SITE Defibrillation Lead System - Longitudinal Surveillance Study of the 4-SITE Lead/Header System 20
Table 21: INGEVITY Pacing Lead - ImageReady MR Conditional Pacing System Clinical Study 21
Table 22: INGEVITY Pacing Lead - INGEVITY Active Fixation and Passive Fixation Pace/ Sense Lead Clinical Study 21
Table 23: INGEVITY Pacing Lead - INGEVITY Observational Trial: Assessment of Routine Experience and Magnet Resonance Imaging (MRI) Usage with a New Lead for Bradycardia Pacing 22
Table 24: Reliance 4-Front Lead - Evaluation of Acuity X4 Quadripolar Coronary Venous Leads and Reliance 4-Front Defibrillation Leads: NAVIGATE X4 23
Table 25: Reliance 4-Front Lead - Reliance 4-Front Active Fixation Defibrillation Lead Post Market Clinical Follow-Up (PMCF) Study 23
Table 26: Reliance 4-Front Lead - RELIANCE 4-FRONT Passive Fixation Defibrillation Lead Post Market Clinical Follow-up (PMCF) Study 24
Table 27: Imricor Medical Systems, Inc. Pipeline Products & Ongoing Clinical Trials Overview 25
Table 28: Magnetic Resonance Imaging (MRI) Compatible Lead - Product Status 25
Table 29: Magnetic Resonance Imaging (MRI) Compatible Lead - Product Description 25
Table 30: LivaNova PLC Pipeline Products & Ongoing Clinical Trials Overview 26
Table 31: Beflex Brady Lead - Product Status 26
Table 32: Beflex Brady Lead - Product Description 27
Table 33: Nano Lead System - Product Status 27
Table 34: Nano Lead System - Product Description 27
Table 35: SonR Tist Lead Positioning - Product Status 28
Table 36: SonR Tist Lead Positioning - Product Description 28
Table 37: SonRFix Lead - Product Status 29
Table 38: SonRFix Lead - Product Description 29
Table 39: Tachy Lead - Product Status 29
Table 40: Tachy Lead - Product Description 30
Table 41: TX Brady Lead - Product Status 30
Table 42: TX Brady Lead - Product Description 30
Table 43: LivaNova PLC - Ongoing Clinical Trials Overview 31
Table 44: SonRFix Lead - SonR FIX Atrial Lead Multi-Centre Clinical Trial 32
Table 45: Mayo Clinic US Pipeline Products & Ongoing Clinical Trials Overview 33
Table 46: Epicardial Pacing/sensing Lead - Product Status 33
Table 47: Epicardial Pacing/sensing Lead - Product Description 33
Table 48: Pacemaker/ICD Lead - Product Status 34
Table 49: Pacemaker/ICD Lead - Product Description 34
Table 50: Medtronic plc Pipeline Products & Ongoing Clinical Trials Overview 35
Table 51: Pacing Lead (Model 4296 LV Lead) - Product Status 35
Table 52: Pacing Lead (Model 4296 LV Lead) - Product Description 35
Table 53: Medtronic plc - Ongoing Clinical Trials Overview 36
Table 54: Pacing Lead (Model 4296 LV Lead) - Attain Ability Family Left Ventricular Lead Chronic Performance Study 37
Table 55: MicroPort Scientific Corporation Pipeline Products & Ongoing Clinical Trials Overview 38
Table 56: Active Pacing Lead - Product Status 38
Table 57: Active Pacing Lead - Product Description 39
Table 58: Passive Pacing Lead - Product Status 39
Table 59: Passive Pacing Lead - Product Description 39
Table 60: MRI Interventions, Inc Pipeline Products & Ongoing Clinical Trials Overview 40
Table 61: MRI-Safe Implantable Cardiac Lead - Product Status 40
Table 62: MRI-Safe Implantable Cardiac Lead - Product Description 41
Table 63: St. Jude Medical, Inc. Pipeline Products & Ongoing Clinical Trials Overview 42
Table 64: Quartet NXT - Double Blend Lead - Product Status 42
Table 65: Quartet NXT - Double Blend Lead - Product Description 43
Table 66: Quartet NXT - Large S-Curve Lead - Product Status 43
Table 67: Quartet NXT - Large S-Curve Lead - Product Description 44
Table 68: Quartet NXT - Small S-Curve Lead - Product Status 44
Table 69: Quartet NXT - Small S-Curve Lead - Product Description 45
Table 70: Tendril MRI lead - Product Status 45
Table 71: Tendril MRI lead - Product Description 46
Table 72: St. Jude Medical, Inc. - Ongoing Clinical Trials Overview 47
Table 73: Tendril MRI lead - A Clinical Evaluation of the SJM MRI Conditional Pacing System in Subjects Undergoing Cardiac Magnetic Resonance Imaging in India 48
Table 74: Tendril MRI lead - Accent Magnetic Resonance Imaging Pacemaker and Tendril Magnetic Resonance Imaging Lead Investigational Device Exemption Study 48
Table 75: Teleflex Incorporated Pipeline Products & Ongoing Clinical Trials Overview 49
Table 76: Pacemaker Lead - Product Status 49
Table 77: Pacemaker Lead - Product Description 49
Table 78: Glossary 85

1.2 List of Figures
Figure 1: Cardiovascular Pacing and Implantable Cardioverter-Defibrillator (ICD) Leads - Pipeline Products by Stage of Development 8
Figure 2: Cardiovascular Pacing and Implantable Cardioverter-Defibrillator (ICD) Leads - Pipeline Products by Territory 9
Figure 3: Cardiovascular Pacing and Implantable Cardioverter-Defibrillator (ICD) Leads - Pipeline Products by Regulatory Path 10
Figure 4: Cardiovascular Pacing and Implantable Cardioverter-Defibrillator (ICD) Leads - Pipeline Products by Estimated Approval Date 11
Figure 5: Cardiovascular Pacing and Implantable Cardioverter-Defibrillator (ICD) Leads - Ongoing Clinical Trials 12

【掲載企業】

Boston Scientific Corporation
Imricor Medical Systems, Inc.
LivaNova PLC
Mayo Clinic US
Medtronic plc
MicroPort Scientific Corporation
MRI Interventions, Inc
St. Jude Medical, Inc.
Teleflex Incorporated

★調査レポート[世界の心血管ペーシングおよび植え込み型除細動器(ICD)リード市場:医療機器パイプライン分析2016]販売に関する免責事項
★調査レポート[世界の心血管ペーシングおよび植え込み型除細動器(ICD)リード市場:医療機器パイプライン分析2016]についてメールでお問い合わせ


◆H&Iグローバルリサーチのお客様(例)◆